Early palliative care lowers hospital costs in patients with advanced cancer
the ONA take:
Earlier palliative care consultation during hospital admission is associated with lower cost of hospital stay for patients admitted with a diagnosis of advanced cancer, a study published in the Journal of Clinical Oncology has shown.
For the prospective study, researchers collected clinical and cost data for adult patients admitted to five hospital in the United States from 2007 to 2011. The researchers identified 969 patients. Of those, 256 received a palliative care consultation and 713 received usual care only.
Results showed that a palliative care consultation within 6 days of admission is estimated to lower costs by $1,312 compared with no intervention. Researchers found that a palliative care consultation within 2 days reduced costs by $2,280. These figures correspond to a 14% and 24% decrease, respectively, in cost of hospital stay.
The findings suggest that early palliative care should be more widely adopted.
Earlier palliative care consultation during hospital admission is associated with lower cost of hospital stay.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|